Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment

被引：0
|
作者：
Cohen, Joshua M. [1 ]
Bibeau, Kristen [1 ]
Galic, Maja [2 ]
Seminerio, Michael J. [1 ]
Ramirez Campos, Verena [3 ]
Singh, Rashmi B. Halker [4 ]
Ailani, Jessica [5 ]
机构：
[1] Teva Pharmaceut, Frazer, PA USA
[2] Teva Pharmaceut, Amsterdam, Netherlands
[3] Teva Pharmaceut, Buenos Aires, DF, Argentina
[4] Mayo Clin, Phoenix, AZ USA
[5] Medstar Georgetown Univ Hosp, Washington, DE USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez-Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S183 - S184
  • [2] Reversion of Patients With Chronic Migraine to an Episodic Migraine Classification With Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Campos, Verena Ramirez
    Singh, Rashmi B. Halker
    Ailani, Jessica
    [J]. NEUROLOGY, 2018, 90
  • [3] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Singh, Halker R. B.
    Cohen, J. M.
    Bibeau, K.
    Galic, M.
    Seminerio, M. J.
    Campos, Ramirez, V
    Ailani, J.
    [J]. HEADACHE, 2018, 58 : 70 - 71
  • [4] Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment (vol 19, P7, 2018)
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [5] Fremanezumab as a preventive treatment for episodic and chronic migraine
    Bigal, Marcelo E.
    Walter, Sarah
    Rapoport, Alan M.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 719 - 728
  • [6] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
  • [7] Reductions in Migraine Frequency With Fremanezumab Treatment in Individuals With Chronic and Episodic Migraine
    Nahas, S. J.
    Ning, X.
    Cohen, J. M.
    Barash, S.
    Campos, V. Ramirez
    Silberstein, S. D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 114 - 114
  • [8] Reductions in Migraine Frequency With Fremanezumab Treatment in Individuals With Chronic and Episodic Migraine
    Nahas, S. J.
    Ning, X.
    Cohen, J. M.
    Barash, S.
    Campos, V. Ramirez
    Silberstein, S. D.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 169 - 169
  • [9] Reductions in Migraine Frequency with Fremanezumab Treatment by Baseline Migraine Frequency Category in Patients with Chronic and Episodic Migraine
    Nahas, Stephanie J.
    Ning, Xiaoping
    Cohen, Joshua M.
    Barash, Steve
    Campos, Verena Ramirez
    Carr, Karen
    Silberstein, Stephen D.
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S133 - S134
  • [10] Efficacy of fremanezumab in patients with chronic and episodic migraine stratified by migraine frequency
    Nahas, Stephanie
    Ning, Xiaoping
    Campos, Verena Ramirez
    Barash, Steve
    Cohen, Joshua
    Silberstein, Stephen
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 216 - 217
12345